Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2025-10-10 | 2025-12-05 | 269232 |
| TEVA-GABAPENTIN | 800MG | TABLET | Actual shortage | 2025-11-20 | 2025-11-20 | 272301 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42613 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-05-29 | 2020-07-09 | 116165 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141125 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 198960 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Actual shortage | 2024-05-30 | 2024-06-20 | 229233 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2019-07-02 | 2020-07-23 | 88164 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167244 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-06-27 | 2024-09-12 | 231424 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2025-05-22 | 2025-06-27 | 258121 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2025-06-05 | 2025-06-27 | 259688 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Resolved | 2024-01-18 | 2024-07-03 | 216460 |
| TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2017-03-13 | 2017-04-25 | 1841 |
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2017-03-17 | 2017-04-03 | 3127 |
| TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43132 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43135 |
| TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2019-11-28 | 2020-01-24 | 99929 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120479 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |